Xuejun Zhang

Tianjin Medical University — China

Immunology and Microbiology · Life Sciences

59h-index13.8kcitations449works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psoriasis: Treatment and Pathogenesis(57), T-cell and B-cell Immunology(49), Dermatology and Skin Diseases(45), melanin and skin pigmentation(42), Immune Cell Function and Interaction(34)

Publications446 total

New Approach for the Quantitative Assessment of Scleral Staphyloma: Discrete Curvature Measure Analysis of the Sclera
Translational Vision Science & Technology·2026Open Access
Determination of the Critical Residence Time in Industrial Continuous Two-Stage Carbonization of PAN-Based Carbon Fibers
ACS Applied Engineering Materials·2025
Exploring the association between immune-inflammation index and carotid plaque formation: a cross-sectional study in a large Chinese health screening population
Frontiers in Endocrinology·2025· 1 citedOpen Access
[The influence of two-way referral model on treatment and prognosis of patients with chronic heart failure].
PubMed·2025
Millimeter-scale error correction with the frequency-adaptive dwell time optimization in spot-sized ion beam figuring
Optics Express·2025Open Access
Germline and somatic second-hit changes in porokeratosis: comprehensive variant spectrum and genotype–phenotype correlation analysis
British Journal of Dermatology·2025
Topical ruxolitinib ± oral baricitinib in the treatment of active non‐segmental vitiligo: A retrospective analysis
Journal of the European Academy of Dermatology and Venereology·2025
A-319, a CD3xCD19 T cell engager, monotherapy for patients with refractory/relapsed B-cell acute lymphoblastic leukemia (r/r B-ALL)
Blood·2025
Beyond depigmentation: A cross-sectional study of 5227 Chinese patients with vitiligo
Journal of Investigative Dermatology·2025
Topical 1.5% ruxolitinib cream for facial refractory segmental vitiligo: A retrospective single-center study
JAAD International·2025Open Access
Efficacy of ruxolitinib cream at different body sites in Chinese patients with nonsegmental vitiligo
Journal of the American Academy of Dermatology·2025
2592MO Fruquintinib (FRUQ) plus sintilimab (SIN) versus axitinib (AXI) or everolimus (EVE) monotherapy as 2L treatment in pts with locally advanced or metastatic renal cell carcinoma (RCC): Results from phase III part of a randomized, open-label, active-controlled phase II/III study (FRUSICA-2)
Annals of Oncology·2025
953P Efficacy of the TLR7 agonist CAN1012 alone or combined with the anti-PD-1 antibody toripalimab
Annals of Oncology·2025
Mid-spatial frequency error characteristics induced by tool influence function in bonnet polishing
Applied Optics·2025
A Hybrid iTransformer-LSTM Architecture for Spatiotemporal WiFi Fingerprint-Based Indoor Localization
2025
Development of an MHC imputation panel highlights independent contributions of HLA amino acid residues and C4 copy number variations to SLE risk
Annals of the Rheumatic Diseases·2025
Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo
JAAD International·2025· 1 citedOpen Access
Heterojunction engineering of the hierarchical SnO2/SnS2 to boost hydrogen evolution reaction in alkaline and acidic solution
Journal of Alloys and Compounds·2025· 1 cited
Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo
Journal of the American Academy of Dermatology·2025· 4 cited
Vision-Language Models Are Not Pragmatically Competent in Referring Expression Generation
arXiv (Cornell University)·2025Open Access
page 1 of 23Next →

Frequent Co-authors

Liangdan Sun(21), Sen Yang(17), Xianbo Zuo(13), Jianjun Liu(13), Wei Huang(8), Yong Cui(8), Fusheng Zhou(7), Min Gao(7), Youwen Zhou(6), Furen Zhang(5), Yunqing Ren(5), Fengyu Zhang(5), Xianyong Yin(5), Xianfa Tang(5), Kai‐Lin Yan(5), Yujun Sheng(4), Peiguang Wang(4), Shengquan Zhang(4), Jin Li(4), Hui Cheng(4)